Clinical Trials on Undifferentiated Ovarian Carcinoma
Total 25836 results
-
Nuvectis Pharma, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingOvarian Cancer | Ovarian Endometrioid Adenocarcinoma | Advanced Solid Tumor | Ovarian Clear Cell Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Clear Cell Tumor | Ovarian Endometrioid Tumor | ARID1A Gene MutationUnited States, United Kingdom
-
Peking University People's HospitalBeijing Weixiao Biotechnology Development LimitedRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian CancerChina
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Celldex TherapeuticsRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Serous Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Platinum-Sensitive Ovarian Carcinoma | Recurrent Fallopian... and other conditionsUnited States
-
National Cancer Institute, NaplesRecruitingLow-grade Serous Ovarian Carcinoma | Recurrent Invasive Borderline Serous Ovarian CancerItaly
-
National Cancer Institute (NCI)TerminatedOvarian CarcinomaUnited States, Israel
-
CHU de Quebec-Universite LavalThe Cancer Research SocietyCompleted
-
All India Institute of Medical Sciences, New DelhiUnknown
-
Hospital for Special Surgery, New YorkRecruitingUndifferentiated Connective Tissue DiseaseUnited States
-
Institut de Cancérologie de LorraineCompleted
-
Rennes University HospitalCompletedOvarian CarcinomaFrance
-
Seoul National University HospitalUnknownFallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Epithelial Ovarian CarcinomaKorea, Republic of
-
University of Wisconsin, MadisonAventis PharmaceuticalsCompletedOvarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Sutro Biopharma, Inc.RecruitingOvarian Cancer | Fallopian Tube Cancer | Ovarian Carcinoma | Ovary Cancer | Primary Peritoneal CarcinomaUnited States
-
Lei LiRecruitingEpithelial Ovarian Cancer | Microsatellite Instability | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Not yet recruitingFallopian Tube Carcinoma | Ovarian Carcinoma | Hereditary Breast and Ovarian Cancer Syndrome | Primary Peritoneal CarcinomaUnited States
-
GlaxoSmithKlineCompletedNeoplasms, OvarianUnited States
-
Life Research Technologies GmbHUnknownOvarian Epithelial CancerAustria, Hungary
-
University Hospital, Basel, SwitzerlandWithdrawnEndometriosis | Endometrioid Carcinoma | Clear Cell Carcinoma
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Ovarian Epithelial CancerUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedPeritoneal Neoplasms | Recurrent Ovarian Carcinoma | Recurrent Uterine Corpus Carcinoma | Cervical Carcinoma | Ovarian Carcinoma | Recurrent Cervical Carcinoma | Uterine Corpus Cancer | Vulvar Carcinoma | Primary Peritoneal Carcinoma | Recurrent Vulvar CarcinomaUnited States
-
Mercy Medical CenterActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Fallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedCaregiver | Stage IIIA Ovarian Cancer | Stage IIIB Ovarian Cancer | Stage IIIC Ovarian Cancer | Stage IV Ovarian CancerUnited States
-
The First People's Hospital of ChangzhouActive, not recruiting
-
Jonsson Comprehensive Cancer CenterTetraLogic Pharmaceuticals; California Institute for Regenerative Medicine... and other collaboratorsWithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | High Grade Ovarian Serous Adenocarcinoma | High Grade Fallopian Tube Serous AdenocarcinomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingOvarian Carcinoma | High-grade Serous Ovarian CarcinomaKorea, Republic of, Spain, Poland, United States, Belgium, Canada, Chile, Israel, Italy, Singapore, Taiwan
-
ARCAGY/ GINECO GROUPMerck Sharp & Dohme LLCRecruitingAddition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT (PembroSCCOHT)Small Cell Ovarian CarcinomaFrance
-
NYU Langone HealthCompletedMicrovascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian CarcinomaOvarian NeoplasmsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Undifferentiated Pleomorphic Sarcoma | Recurrent Undifferentiated Pleomorphic Sarcoma | Locally Advanced Undifferentiated Pleomorphic Sarcoma | Unresectable Undifferentiated Pleomorphic SarcomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage IV Borderline Ovarian...Canada
-
Sutro Biopharma, Inc.RecruitingOvarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Ovarian Carcinoma | Endometrioid Adenocarcinoma | Ovary Cancer | Primary Peritoneal CarcinomaUnited States, Spain
-
National Cancer Institute (NCI)RecruitingRecurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Recurrent Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian CarcinomaUnited States
-
Dana-Farber Cancer InstituteImmunityBio, Inc.Not yet recruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Ovarian Carcinoma | Recurrent Ovary Cancer | Ovarian Carcinoma, RecurrentUnited States
-
Seoul National University HospitalSamsung Medical Center; Takeda; Asan Medical Center; Yonsei UniversityNot yet recruitingOvarian Cancer | Epithelial Ovarian Cancer | Ovarian Cancer Stage IV | Ovarian Cancer Stage III
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
AGO Research GmbHHoffmann-La RocheActive, not recruitingRecurrent Ovarian CarcinomaNorway, Spain, France, Switzerland, Denmark, Germany, Sweden, Belgium, Finland, Austria, Estonia, Lithuania
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)RecruitingStage IIIA Ovarian Cancer | Stage IIIB Ovarian Cancer | Stage IIIC Ovarian Cancer | Stage IV Ovarian CancerUnited States
-
Thomas Jefferson UniversityContext Therapeutics Inc.Active, not recruitingRefractory Endometrial Carcinoma | Refractory Endometrial Endometrioid Adenocarcinoma | Refractory Endometrial Adenocarcinoma | Refractory Endometrial Clear Cell Adenocarcinoma | Refractory Endometrial Mixed Cell Adenocarcinoma | Refractory Endometrial Serous Adenocarcinoma | Refractory Endometrial...United States
-
NHS Greater Glasgow and ClydeBoehringer Ingelheim; Cancer Research UK; European Organisation for Research... and other collaboratorsUnknownOvarian Clear Cell Carcinoma | Endometrial Clear Cell CarcinomaUnited Kingdom
-
PfizerTerminatedOvarian Neoplasms | Ovarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Ovarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Sohag UniversityRecruiting
-
Lawson Health Research InstituteActive, not recruitingCarcinosarcoma | Endometrioid Adenocarcinoma | Clear Cell Carcinoma | Serous Carcinoma | Dedifferentiated CarcinomaCanada
-
Dana-Farber Cancer InstituteRecruitingOvarian Cancer | Endometrial Cancer | Ovarian Carcinoma | Ovarian Cancer Stage IV | Ovarian Cancer Stage III | Ovarian Cancer Stage 3 | Endometrial Cancer StageUnited States
-
NovoCure Ltd.UnknownOvarian CarcinomaSwitzerland, Belgium, Germany, Spain
-
HaEmek Medical Center, IsraelTerminatedOvarian CarcinomaIsrael
-
Dana-Farber Cancer InstituteCelula, Inc.TerminatedStage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
Burzynski Research InstituteTerminatedStage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
National Cancer Institute (NCI)CompletedUterine Carcinosarcoma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Endometrial Serous Adenocarcinoma | Lung Carcinoid Tumor | Metastatic... and other conditionsUnited States, Canada
-
Samsung Medical CenterCompletedWHYX Lesion | Extremely Well Differentiated Intestinal-type AdenocarcinomaKorea, Republic of
-
Daiichi Sankyo, Inc.CompletedOvarian Cancer Stage IIIC | Ovarian Cancer Stage IVUnited States
-
University Health Network, TorontoCompletedPlatinum-resistant Epithelial Ovarian CancerCanada